Aldeyra Therapeutics, Inc. - Common Stock (NQ:ALDX)

1.170 -0.120 (-9.30%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aldeyra Therapeutics, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Aldeyra Therapeutics Reports Third-Quarter 2021 Financial Results and Recent Corporate Highlights

October 28, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

Aldeyra Therapeutics Schedules Webcast and Conference Call to Report Third-Quarter 2021 Financial Results and Discuss Recent Business Highlights

October 21, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

Aldeyra Therapeutics to Participate in the Virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

September 09, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Aldeyra Therapeutics to Participate in Upcoming Virtual Investor Conferences

September 02, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

Aldeyra Therapeutics (ALDX) Q2 2021 Earnings Call Transcript ↗

August 07, 2021

ALDX earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Aldeyra Therapeutics Reports Second-Quarter 2021 Financial Results and Recent Corporate Highlights

August 05, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

Aldeyra Secures US Orphan Drug Tag For Its Retinitis Pigmentosa Candidate ↗

August 04, 2021

The FDA has granted orphan drug designation to Aldeyra Therapeutics Inc's (NASDAQ: ALDX) ADX-2191 to treat retinitis pigmentosa (RP). ADX-2191 is a...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 04, 2021

Gainers BeyondSpring (NASDAQ:BYSI) stock increased by 337.79% to $42.16 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6...

Via Benzinga

Aldeyra Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-2191 to Treat Retinitis Pigmentosa

August 04, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

Aldeyra Therapeutics to Participate in Upcoming Virtual Investor Conferences

August 03, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

Aldeyra Therapeutics Schedules Webcast and Conference Call to Report Second-Quarter 2021 Financial Results and Discuss Recent Business Highlights

July 29, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

Aldeyra Stock Trading Higher On FDA Orphan Drug Tag For Primary Vitreoretinal Lymphoma Candidate ↗

July 20, 2021

The FDA has granted Orphan Drug Designation to Aldeyra Therapeutics Inc's (NASDAQ: ALDX) ADX-2191 (methotrexate for intravitreal injection) for primary...

Via Benzinga

Aldeyra Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-2191 to Treat Primary Vitreoretinal Lymphoma

July 20, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 19, 2021

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock moved upwards by 67.6% to $14.28 during Monday's pre-market session. The company's market cap stands at $684.2...

Via Benzinga

Aldeyra Therapeutics Joins the Russell 2000® and Russell 3000® Indexes

July 01, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference

May 27, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics, And More ↗

May 08, 2021

Insider buying can be an encouraging signal for investors, especially when markets are near all-time highs. Some insiders have taken advantage of initial public offerings. A few chief executive...

Via Talk Markets

The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics And More ↗

May 08, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders have taken advantage of initial...

Via Benzinga

Aldeyra Therapeutics (ALDX) Q1 2021 Earnings Call Transcript ↗

May 06, 2021

ALDX earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Aldeyra Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Highlights

May 06, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 29, 2021

Gainers Galera Therapeutics (NASDAQ:GRTX) shares increased by 42.2% to $9.4 during Thursday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Aldeyra Therapeutics Schedules Webcast and Conference Call to Report First-Quarter 2021 Financial Results and Discuss Recent Business Highlights

April 29, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

60 Biggest Movers From Yesterday ↗

April 29, 2021

Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares gained 75.6% to settle at $43.73 on Wednesday. The company recently said it paid $1 million towards acquisition of...

Via Benzinga

Aldeyra Therapeutics, Inc. Announces Pricing of $125 Million Public Offering of Common Stock

April 28, 2021

From Aldeyra Therapeutics, Inc.

Via Business Wire

Why Aldeyra Therapeutics Stock Is Sinking Today ↗

April 28, 2021

The company plans to conduct a public stock offering.

Via The Motley Fool

41 Stocks Moving In Wednesday's Mid-Day Session ↗

April 28, 2021

Gainers Aurora Mobile Limited (NASDAQ: JG) shares climbed 21.3% to $4.27 after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per...

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.